From: Assessment of plasminogen activator inhibitor-1 in obese Egyptian children
Obese group (mean ± SD) | Control group (mean ± SD) | p value | |
---|---|---|---|
Height (SDS) | 0.467 ± 1.10 | − 0.765 ± 0.577 | 0.042 |
Weight (SDS) | 3.16 ± 1.52 | − 0.0319 ± 0.594 | 0.000** |
BMI (kg/m2) | 29.87 ± 3.35 | 18.22 ± 1.87 | 0.000** |
BMI (SDS) | 3.123 ± 0.607 | − 0.776 ± 0.789 | 0.000** |
Waist circumference (cm) | 88.38 ± 8.28 | 57.33 ± 4.76 | 0.000** |
Hip circumference (cm) | 94.08 ± 9.87 | 68.86 ± 7.33 | 0.000** |
W/H ratio | 0.938 ± 0.053 | 0.830 ± 0.047 | 0.000** |
Biceps skin fold (SDS) | 1.9 ± 1.72 | 1.15 ± 1.2 | 0.000** |
Triceps skin fold (SDS) | 2 ± 1.77 | 0.80 ± 1.08 | 0.000** |
Subscapular skin fold (SDS) | 3 ± 4.96 | 0.9 1 ± 1.06 | 0.000** |
Systolic Bp (mmHg) | 115.28 ± 9.06 | 101.40 ± 6.38 | 0.000** |
Diastolic Bp (mmHg) | 77.79 ± 11.56 | 63.79 ± 5.97 | 0.000** |
Total cholesterol (mg/dl) | 168.40 ± 28.44 | 144.17 ± 25.97 | 0. 000 |
Triglycerides (mg/dl) | 100.51 ± 29.67 | 57.60 ± 15.02 | 0.000 |
HDL-c (mg/dl) | 41.23 ± 10.87 | 43.191 ± 11.037 | 0.412 |
LDL-c (mg/dl) | 103.05 ± 32.39 | 89.74 ± 20.74 | 0.027 |
FBS (mg/dl) | 94.37 ± 9.51 | 87.69 ± 9.94 | 0.001 |
Insulin (μIU/ml) | 17.75 ± 8.067 | 7.78 ± 2.58 | 0.000 |
HOMA-IR | 4.14 ± 1.94 | 1.67 ± 0.609 | 0.000 |
PAI-1 (ng/dl) | 47.98 ± 17.42 | 28.00 ± 11.35 | 0.000 |